Literature DB >> 8382202

Transpalatal insertion of radioactive gold grain for the treatment of persistent and recurrent nasopharyngeal carcinoma.

D Choy1, J S Sham, W I Wei, C M Ho, P M Wu.   

Abstract

PURPOSE: To evaluate the efficacy of radioactive gold grain implant via the split palate approach in the control of locally recurrent or persistent nasopharyngeal carcinoma. METHODS AND MATERIAL: Forty-three patients, 10 for persistent NPC, 28 for first relapse in the nasopharynx, and five for second relapse in the nasopharynx, were treated. The diameter of the tumors at the time of gold grain implant ranged from 0.5 to 5 cm, the number of gold grains inserted varied from 4 to 14, the median number was seven.
RESULTS: There was no significant difference in the control of the primary tumor for persistent disease (80% at 5 years), first relapse (61% at 5 years) and second relapse (80% at 3 years), p = 0.8845. The difference in survival between the three subgroups of patients, however, was highly significant (p = 0.0040). Thirty patients had CT evaluation before gold grain implant and the tumor was found confined to the nasopharynx in 21, in the remaining nine patients erosion of the sphenoid sinus or other parts of the base of skull was noted. The difference in the control between those patients with tumors confined to the nasopharynx and those patients with extranasopharyngeal extension of tumor almost reached statistical significance (81% and 44% respectively at 5 years, p = 0.0554). For the six patients who developed local recurrence after gold grain implant and were evaluable for the pattern of failure, the recurrent tumors were considered originating from another region of the nasopharynx in four, and in-field failure in the other two cases.
CONCLUSION: Radioactive gold grain implant as salvage treatment provides satisfactory control of persistent and recurrent nasopharyngeal carcinoma. The local control was better when the tumor was localized to the nasopharynx, thus underlines the importance of close follow-up for early recognition of relapse and persistent tumor. However, such patients still suffered from high incidence of regional and distant failure, the pathophysiology and management of which require further investigation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8382202     DOI: 10.1016/0360-3016(93)90073-5

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  8 in total

1.  Radiotherapy for head and neck cancer.

Authors:  Shyh-An Yeh
Journal:  Semin Plast Surg       Date:  2010-05       Impact factor: 2.314

2.  Current management strategy of nasopharyngeal carcinoma.

Authors:  William I Wei; Dora L W Kwong
Journal:  Clin Exp Otorhinolaryngol       Date:  2010-03-30       Impact factor: 3.372

Review 3.  Current treatment options for recurrent nasopharyngeal cancer.

Authors:  Carlos Suárez; Juan P Rodrigo; Alessandra Rinaldo; Johannes A Langendijk; Ashok R Shaha; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-09-24       Impact factor: 2.503

4.  Diagnosis of post-radiotherapy local failures in nasopharyngeal carcinoma: a prospective institutional study.

Authors:  Puneet Kumar Bagri; Mukesh Kumar Singhal; Daleep Singh; Akhil Kapoor; Shankar Lal Jakhar; Neeti Sharma; Surender Beniwal; Harvindra Singh Kumar; Ajay Sharma; Megh Raj Bardia
Journal:  Iran J Cancer Prev       Date:  2014

5.  Radiotherapy-induced anti-tumor immune response and immune-related adverse events in a case of recurrent nasopharyngeal carcinoma undergoing anti-PD-1 immunotherapy.

Authors:  T Finazzi; T Rordorf; K Ikenberg; G F Huber; M Guckenberger; H I Garcia Schueler
Journal:  BMC Cancer       Date:  2018-04-06       Impact factor: 4.430

6.  Fibre-optic endoscope-guided three-dimensional high-dose-rate interstitial brachytherapy for residual nasopharyngeal carcinoma after conventional external beam radiotherapy.

Authors:  Xiaoni Zhang; Ning Wu; Zhipeng Zhao; Dongmei Han; Mingyuan He; Wei Yang; Guanghui Cheng
Journal:  J Contemp Brachytherapy       Date:  2019-06-28

7.  Comparison of single versus fractionated dose of stereotactic radiotherapy for salvaging local failures of nasopharyngeal carcinoma: a matched-cohort analysis.

Authors:  Daniel T T Chua; Shao-Xiong Wu; Victor Lee; Janice Tsang
Journal:  Head Neck Oncol       Date:  2009-05-23

8.  Validation of a prognostic scoring system for locally recurrent nasopharyngeal carcinoma treated by stereotactic radiosurgery.

Authors:  Daniel T T Chua; Kwan-Ngai Hung; Victor Lee; Sherry C Y Ng; Janice Tsang
Journal:  BMC Cancer       Date:  2009-04-29       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.